These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Down syndrome and Alzheimer's disease: Common pathways, common goals. Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383 [TBL] [Abstract][Full Text] [Related]
29. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review. Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250 [TBL] [Abstract][Full Text] [Related]
30. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment. Korczyn AD Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060 [TBL] [Abstract][Full Text] [Related]
31. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Caroli A; Prestia A; Wade S; Chen K; Ayutyanont N; Landau SM; Madison CM; Haense C; Herholz K; Reiman EM; Jagust WJ; Frisoni GB; Alzheimer Dis Assoc Disord; 2015; 29(2):101-9. PubMed ID: 25437302 [TBL] [Abstract][Full Text] [Related]
32. The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil. Fonseca LM; Haddad GG; Mattar GP; Oliveira MC; Simon SS; Guilhoto LM; Busatto GF; Zaman S; Holland AJ; Hoexter MQ; Bottino CM Braz J Psychiatry; 2019; 41(3):225-233. PubMed ID: 30365671 [TBL] [Abstract][Full Text] [Related]
34. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117 [TBL] [Abstract][Full Text] [Related]
35. Neuropsychological correlates of amyloid precursor protein in Alzheimer's disease. Thomas LD Int J Nurs Pract; 1996 Mar; 2(1):29-32. PubMed ID: 9305029 [TBL] [Abstract][Full Text] [Related]
36. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029 [TBL] [Abstract][Full Text] [Related]
37. A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction. Spooner A; Chen E; Sowmya A; Sachdev P; Kochan NA; Trollor J; Brodaty H Sci Rep; 2020 Nov; 10(1):20410. PubMed ID: 33230128 [TBL] [Abstract][Full Text] [Related]
38. [Early Mental Test--developing a screening test for mild cognitive impairment]. Kálmán J; Pákáski M; Hoffmann I; Drótos G; Darvas G; Boda K; Bencsik T; Gyimesi A; Gulyás Z; Bálint M; Szatlóczki G; Papp E Ideggyogy Sz; 2013 Jan; 66(1-2):43-52. PubMed ID: 23607229 [TBL] [Abstract][Full Text] [Related]
39. Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease. Vannini P; Amariglio R; Hanseeuw B; Johnson KA; McLaren DG; Chhatwal J; Pascual-Leone A; Rentz D; Sperling RA Neuropsychologia; 2017 May; 99():343-349. PubMed ID: 28385579 [TBL] [Abstract][Full Text] [Related]
40. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities. Ball SL; Holland AJ; Treppner P; Watson PC; Huppert FA Br J Clin Psychol; 2008 Mar; 47(Pt 1):1-29. PubMed ID: 17681112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]